WO2008015698A2 - A process for manufacturing an herbal composition for curing psoriasis and herbal composition made thereof - Google Patents
A process for manufacturing an herbal composition for curing psoriasis and herbal composition made thereof Download PDFInfo
- Publication number
- WO2008015698A2 WO2008015698A2 PCT/IN2007/000214 IN2007000214W WO2008015698A2 WO 2008015698 A2 WO2008015698 A2 WO 2008015698A2 IN 2007000214 W IN2007000214 W IN 2007000214W WO 2008015698 A2 WO2008015698 A2 WO 2008015698A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- extract
- leaf extract
- herbal composition
- sunlight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 201000004681 Psoriasis Diseases 0.000 title claims description 24
- 239000000284 extract Substances 0.000 claims abstract description 76
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 235000008216 herbs Nutrition 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 10
- 244000118350 Andrographis paniculata Species 0.000 claims abstract description 8
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 8
- 244000286838 Eclipta prostrata Species 0.000 claims abstract description 8
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 8
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 8
- 240000006075 Sapindus trifoliatus Species 0.000 claims abstract description 8
- 241000735506 Senna italica Species 0.000 claims abstract description 8
- 240000003801 Sigesbeckia orientalis Species 0.000 claims abstract description 8
- 235000003407 Sigesbeckia orientalis Nutrition 0.000 claims abstract description 8
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 8
- 241000208251 Gymnema Species 0.000 claims abstract description 7
- 240000004482 Withania somnifera Species 0.000 claims abstract description 7
- 235000001978 Withania somnifera Nutrition 0.000 claims abstract description 7
- SASUFNRGCZMRFD-JCUIILOWSA-N withanolide D Chemical compound C1C(C)=C(C)C(=O)O[C@H]1[C@](C)(O)[C@@H]1[C@@]2(C)CC[C@@H]3[C@@]4(C)C(=O)C=C[C@H](O)[C@@]54O[C@@H]5C[C@H]3[C@@H]2CC1 SASUFNRGCZMRFD-JCUIILOWSA-N 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 239000004677 Nylon Substances 0.000 claims abstract description 5
- 239000004744 fabric Substances 0.000 claims abstract description 5
- 229920001778 nylon Polymers 0.000 claims abstract description 5
- 239000002689 soil Substances 0.000 claims abstract description 5
- 239000011812 mixed powder Substances 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000004575 stone Substances 0.000 claims abstract description 4
- 239000012676 herbal extract Substances 0.000 claims abstract description 3
- 238000010298 pulverizing process Methods 0.000 claims abstract description 3
- 238000007873 sieving Methods 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 208000017520 skin disease Diseases 0.000 description 5
- 206010024229 Leprosy Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 240000001432 Calendula officinalis Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 244000044980 Fumaria officinalis Species 0.000 description 2
- 235000006961 Fumaria officinalis Nutrition 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 244000274883 Urtica dioica Species 0.000 description 2
- 235000009108 Urtica dioica Nutrition 0.000 description 2
- 240000005592 Veronica officinalis Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000010871 livestock manure Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 241000722941 Achillea Species 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010012239 Delusion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000006353 Filariasis Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000208253 Gymnema sylvestre Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000580955 Sapindus mukorossi Species 0.000 description 1
- 208000019229 Spleen disease Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000010465 Veronica officinalis Nutrition 0.000 description 1
- 241000244005 Wuchereria bancrofti Species 0.000 description 1
- 206010048232 Yawning Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000027499 body ache Diseases 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 231100000868 delusion Toxicity 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000006036 elephantiasis Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000004052 folic acid antagonist Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000012674 herbal formulation Substances 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000027140 splenic disease Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Definitions
- the present invention relates to process for manufacturing an herbal composition for curing Psoriasis. Also it relates to an herbal composition manufactured by the aforesaid process.
- Psoriasis is a skin disorder that includes the presence of small elevations of the skin that may be characterized as elevated red lesions, plaques or pustules on the skin which eventually result in silvery scales. These silvery scales and plaque are the result of accelerated epidermal proliferation and the metabolic activity and proliferation of capillaries in the dermal region and the invasion of the dermis and epidermis by inflammatory cells. More specifically, the capillaries in the dermal region become tortuous and dilated as well as suffering an inflammatory reaction causing the skin to redden.
- psoriasis has been treated topically with coal tar derivatives as well as salicylic acid with limited success.
- Corticosteroids and other similar drugs have been found effective for serious cases of psoriasis.
- Many of these drugs produce serious side effects, and in some cases once the drugs are discontinued, the psoriasis recurs with marked exacerbation.
- Other forms of treatment include folic acid antagonists, ionizing radiation therapy, a variety of combinations of ointments and polyethylene films, sunlight and ultraviolet baths.
- U.S. Pat. No. 5,425,954 issued on Jun. 20, 1995 to Thompson et al. and provides for a composition for topical application to the skin, comprising a mixture of Panthenol (B.sub.5), Cod Liver Oil, Alpha Tocopherol Acetate, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Threonine, and Valine in admixture with a suitable carrier.
- U.S. Pat. No. 4,981,681 issued on Jan. 1, 1991 to Tosti and relates to a method for treating psoriasis and more particularly it relates to a method of treating psoriasis by systematic and periodic application of several selected ingredients including the active ingredient Salicylic Acid.
- U.S. Pat. No. 5,886,038 issued on Mar. 23, 1999 to Glenn et al. and relates to a pharmaceutical composition for use in the treatment of psoriasis, having isopropyl myristate as its only active ingredient.
- U.S. Pat. No. 5,165,932 issued on Nov. 24, 1992 to Horvath and relates to therapeutical compositions on medical herb basis for the treatment of psoriasis and the preparation of the same.
- the medical herbs used in the invention are Allium, sativum/ garlic/, Urtica dioica/ common nettle/, Chelidonium majus/m ⁇ kweed/, Veronica officinalis /veronica/, Calendula officinalis/ calendula or marigold/, Achillea herba/ millefolium/ yarrow/ and Fumaria officinalis/fumitory, earth-gall.
- the main object of the present invention is to provide a process for manufacturing an herbal composition for curing Psoriasis.
- Further object of present invention is to provide an herbal composition manufactured by the aforesaid mentioned process.
- a process for manufacturing a herbal composition comprises the steps of:
- an herbal composition comprises:
- the herbal composition of the present invention essentially comprising of following main ingredients:
- This soap nut powder is used for shampooing to reduce overheat in the body, skin allergies.
- Medasinghi It is effective for curing leprosy, ulcers, itches, scabies and all skin diseases. It also cures pain and asthma.
- the leaves extract will be used to all type of skin diseases. It heals wounds on the body very fast if you apply their leaves on the wounds.
- This ingredient is used for bathing. All black spots on skin will disappear. It acts against dandruff and keeps you free from dandruff when used for shampooing. It gives strength to your hair by keeping it black. It is peculiar in curing diabetes.
- T.B Phlegm
- Fistula and many other diseases. This is good for health. It gives strength and complexion. This is useful in developing your muscles. It also cures cough, leprosy, esnofilia. It gives strength to waist. It gives strength to nerves. It also cures joint pains.
- an herbal composition comprises the following ingredients in proper amount:
- the formulations of the present invention are not a mere admixture resulting in mere aggregation of the properties of individual ingredients but in a synergistic mixture resulting in enhanced curative properties. Also the clinical trial has been conducted on this newly developed herbal composition and it is surprisingly found that efficacy is improved by using this formulation instead of using individual ingredients of the formulation. Also the clinical trials have been conducted on the patients suffering from the Psoriasis. All have applied the formulation of the present invention on their skin externally once or twice a day depending on the extent of Psoriasis and it has been found that patients get cured in a shorter span of time with least or no side effects. Extent of side effect is varying from person to person. No severe side effect is found. Example:
- the herbs are selected and cultivated in the red soil using bio-fertilizer manure or all natural waste. These are harvested in Non-sunlight after the maturity period and cut after 10 or 12 days in a non-sunlight or shed with hygienic condition preferably on stone. Subsequently dried in sunlight for 1 to 2 days. Then extracts of above herbs in following percentage by weight are selected:
- herb extract are grinded separately in a grinder with 1500 rpm to make powder form and pulverized/blended in the specific proportion as given above in the pulverizer/blender for thorough mixing with speed of 500 rpm for 45 minutes.
- resultant mixture sieved through the nylon cloth of 150 mesh size to obtain the required particle size of the active ingredients which.
- the formulation of the present invention is available in powdered form. However, it should be understood that the invention is not limited in this regard, and the relative amounts of these ingredients can be varied to achieve similar results.
- the invention provides herbal composition for curing Psoriasis which is very well used in the medicinal field and drug industries.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A process for manufacturing an herbal composition comprises the steps of: a. selecting the extracts of the following Herbs in the given percentage by weight: 13 % by weight fruit extract of Ritha (Sapindus trif oliatus) 18 % by weight leaf extract of Medasinghi (Gymnema sylvastre) 12 % by weight fruit & seed extract of AmIa (Phyllanthus emblica) 10 % by weight leaf extract of Kalmegh (Andrographis paniculata) 3 % by weight root extract of Veeranmool (Andropogan muricatus) 5 % by weight leaf extract of KaIy ani (Cassia obovata) 10 % by weight stem and leaf extract of Wonga (Achyrantus aspera) 12 % by weight stem and leaf extract of Bhangra (Eclipta prostrata) 12 % by weight root extract of Haldi (Curcuma longa) 5 % by weight root extract of Aswagandha (Withania somnifera) wherein aforesaid mentioned herbal extracts are cultivated in red soil and harvested in non-sunlight after the maturity period and cut in non-sunlight in a hygienic condition probably on clean stone for hygienic purpose and dryed in sunlight before grinding for one to two days; b. grinding the above Herbs separately in a grinder at a speed of 1500 rpm; c. pulverizing/blending the ingredients in their specific proportion as given above in a pulverizer/blender run at a speed of 500 rpm for 30 to 60 minutes; d. sieving the mixed powder through a sieve made of nylon cloth of 150 mesh size.
Description
A Process for manufacturing an herbal composition for curing Psoriasis and herbal composition made thereof
Field Of Invention:
The present invention relates to process for manufacturing an herbal composition for curing Psoriasis. Also it relates to an herbal composition manufactured by the aforesaid process.
Prior Art:
Psoriasis is a skin disorder that includes the presence of small elevations of the skin that may be characterized as elevated red lesions, plaques or pustules on the skin which eventually result in silvery scales. These silvery scales and plaque are the result of accelerated epidermal proliferation and the metabolic activity and proliferation of capillaries in the dermal region and the invasion of the dermis and epidermis by inflammatory cells. More specifically, the capillaries in the dermal region become tortuous and dilated as well as suffering an inflammatory reaction causing the skin to redden.
The exact mechanism which triggers the abnormal cell prolif eration is not known, though it is believed there may be biochemical stimuli and environmental factors. The severity and course of psoriasis can vary greatly depending on the individual, but in general this chronic skin condition recurs throughout the lif e of the individual with varying intervals of one month to many years.
Over the years a wide variety of methods of treatment for psoriasis, both topical and systemic, which inhibit the cell division have been developed. In general, these methods have met with limited short term success and are not very well understood. As the disease requires treating the individual intermittently during their lifetime,
treatment risk increases with treatment length since common medicaments evidence cumulative long term side effects.
Historically, psoriasis has been treated topically with coal tar derivatives as well as salicylic acid with limited success. Corticosteroids and other similar drugs have been found effective for serious cases of psoriasis. Unfortunately many of these drugs produce serious side effects, and in some cases once the drugs are discontinued, the psoriasis recurs with marked exacerbation. Other forms of treatment include folic acid antagonists, ionizing radiation therapy, a variety of combinations of ointments and polyethylene films, sunlight and ultraviolet baths.
Prior art psoriasis medications and methods of medical treatment have been devised to address the aforenoted problems. For example, U.S. Pat. No. 5,425,954 issued on Jun. 20, 1995 to Thompson et al. and provides for a composition for topical application to the skin, comprising a mixture of Panthenol (B.sub.5), Cod Liver Oil, Alpha Tocopherol Acetate, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Threonine, and Valine in admixture with a suitable carrier.
U.S. Pat. No. 5,990,100 issued on Nov. 23, 1999 to Rosenbert et al. and this patent relates to pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti- psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
U.S. Pat. No. 4,981,681 issued on Jan. 1, 1991 to Tosti and relates to a method for treating psoriasis and more particularly it relates to a method of treating psoriasis by systematic and periodic application of several selected ingredients including the active ingredient Salicylic Acid.
U.S. Pat. No. 5,886,038 issued on Mar. 23, 1999 to Glenn et al. and relates to a pharmaceutical composition for use in the treatment of psoriasis, having isopropyl myristate as its only active ingredient.
U.S. Pat. No. 5,165,932 issued on Nov. 24, 1992 to Horvath and relates to therapeutical compositions on medical herb basis for the treatment of psoriasis and the preparation of the same. The medical herbs used in the invention are Allium, sativum/ garlic/, Urtica dioica/ common nettle/, Chelidonium majus/mϋkweed/, Veronica officinalis /veronica/, Calendula officinalis/ calendula or marigold/, Achillea herba/ millefolium/ yarrow/ and Fumaria officinalis/fumitory, earth-gall.
The conventional Herbal formulations, which are available, are not found effective for curing the above diseases. Also they all having up to some extent the risk of side effects. Therefore, there is a need to have different combination in full therapeutic effect of the active ingredients present in the different types of Herbs to give synergy effect with minimal or no side effect. Thus a composition of treatment for psoriasis which allows for the successful treatment by reducing the frequency of the recurrence of the psoriasis is desirable.
Object of Invention:
The main object of the present invention is to provide a process for manufacturing an herbal composition for curing Psoriasis.
Further object of present invention is to provide an herbal composition manufactured by the aforesaid mentioned process.
Another object is to provide herbal medicament for curing Psoriasis with least or no side effect.
Another object is to provide herbal medicament for curing Psoriasis in a shorter span of time.
Accordingly there is provided a process for manufacturing a herbal composition comprises the steps of:
a. selecting the extracts of the following Herbs in the given percentage by weight:
1. 13 % by weight fruit extract of Ritha (Sapindus trifoliatus)
2. 18% by weight leaf extract of Medasinghi (Gymnema sylvastre)
3. 12% by weight fruit & seed extract of AmIa (Phyllanthus emblica)
4. 10% by weight leaf extract of Kalmegh (Andrographis paniculata)
5. 3% by weight root extract of Veeranmool (Andropogan muricatus)
6. 5% by weight leaf extract of Kalyani (Cassia obovata)
7. 10% by weight stem and leaf extract of Wonga (Achyrantus aspera)
8. 12% by weight stem and leaf extract of Bhangra (Eclipta prostrata)
9. 12% by weight root extract of Haldi (Curcuma longa)
10. 5% by weight root extract of Aswagandha (Withania somnifera)
wherein aforesaid mentioned herbal extracts are cultivated in red soil and harvested in non-sunlight after the maturity period and cut in non-sunlight in a hygienic condition probably on clean stone for hygienic purpose and dried in sunlight before grinding for one to two days;
a. grinding the above Herbs separately in a grinder at a speed of 1500 rpm;
b. pulverizing/blending the ingredients in their specific proportion as given above in a pulverizer/ blender run at a speed of 500 rpm for 30 to 60 minutes;
c. sieving the mixed powder through a sieve made of nylon cloth of 150 mesh size.
Also there is provided an herbal composition comprises:
1. 13 % by weight fruit extract of Ritha (Sapindus trifoliatus)
2. 18% by weight leaf extract of Medasinghi (Gymnema sylvastre)
3. 12% by weight fruit & seed extract of AmIa (Phyllanthus emblica)
4. 10% by weight leaf extract of Kalmegh (Andrographis paniculata)
5. 3% by weight root extract of Veeranmool (Andropogan muricatus)
6. 5% by weight leaf extract of Kalyani (Cassia obovata)
7. 10% by weight stem and leaf extract of Wonga (Achyrantus aspera)
8. 12% by weight stem and leaf extract of Bhangra (Eclipta prostrata)
9. 12% by weight root extract of Haldi (Curcuma longa)
10. 5% by weight root extract of Aswagandha (Wϊthania somnifera)
Detailed description of the invention:
Now following description will explain the invention in details.
The herbal composition of the present invention essentially comprising of following main ingredients:
1. SAPINDUS TRIFOLIATUS
Common Name : Ritha
It is used to get relief from headache by applying it to the forehead. It is also used to cure asthma, epitasis, eye diseases and other yawns. This soap nut powder is used for shampooing to reduce overheat in the body, skin allergies.
2. GYMNEMA SYLVESTRE
Common Name : Medasinghi
It is effective for curing leprosy, ulcers, itches, scabies and all skin diseases. It also cures pain and asthma. The leaves extract will be used to all type of skin diseases. It heals wounds on the body very fast if you apply their leaves on the wounds.
3. PHYLLANTHUS EMBLICA
Common Name : AmIa
It is best for removing scabies, skin diseases and pains.
4. ANDROGRAPHIS PANICULATA
Common Name : Kalmegh
It cures ulcers, cough, phlegm, anemia and headache. It gives strength to stomach, increase semen & cures all kidney diseases. It also cures fever and cold diseases.
5. ANDROPOGAN MURICATUS
Common Name : Veeranmool
It is used to kill inflammation, diarrhea, leucorrhea, excessive bile, delusion, haematemesis, T.B, rheumatic fever etc.
6. CASSIA OBOVATA
Common Name : Kalyani
This ingredient is used for bathing. All black spots on skin will disappear. It acts against dandruff and keeps you free from dandruff when used for shampooing. It gives strength to your hair by keeping it black. It is peculiar in curing diabetes.
7. ACHYRANTUS ASPERA
Common Name : Wonga
This ingredient cures all types of leprosy, itches, eczema, boils and skin diseases.
8. ECLIPTA PROSTRATA
Common Name : Bhangra
It cures leprosy, itches, cough, fever, asthma, phlema and anemia. It is good for eyes. It keeps your hair black. It gives strength to your body. It is also useful to cure Elephantiasis. It relieves pain like body-ache, headache etc. It is also cures liver & spleen diseases.
9. CURCUMA LONGA
Common Name : Haldi
It purifies blood and for digestive system. It cures itching and bacterial diseases.
10. WITHANIA SOMNIFERA
Common Name : Aswagandha
This cures T.B, Phlegm, Fistula and many other diseases. This is good for health. It gives strength and complexion. This is useful in developing your muscles. It also cures cough, leprosy, esnofilia. It gives strength to waist. It gives strength to nerves. It also cures joint pains.
Above mentioned herbs are naturally occurring and cultivated through out India most preferably in Andhra Pradesh in forest. The selection of these herbs from the region as well as the climatic condition, soil, manure of all this have effects on the raw material used.
According to the present invention an herbal composition comprises the following ingredients in proper amount:
1. 13 % by weight fruit extract of Ritha (Sapindus trifoliatus)
2. 18% by weight leaf extract of Medasinghi (Gymnema sylvastre)
3. 12% by weight fruit & seed extract of AmIa (Phyllanthus emblica)
4. 10% by weight leaf extract of Kalmegh (Andrographis paniculata)
5. 3 % by weight root extract of Veeranmool (Andropogan muricatus)
6. 5 % by weight leaf extract of Kalyani (Cassia obovata)
7. 10% by weight stem and leaf extract of Wonga (Achyrantus aspera)
8. 12% by weight stem and leaf extract of Bhangra (Eclipta prostrata)
9. 12% by weight root extract of Haldi (Curcuma longa)
10. 5% by weight root extract of Aswagandha (Withania somnifera)
Then according to process of the present invention above mentioned herbs are ground separately in a grinder at a speed of 1500 rpm. Then these are pulverized/blended in their specific proportion as given above in a pulverizer/blender run at a speed of 500 rpm for 30 to 60 minutes. Then the mixed powder is sieved through a sieve made of nylon cloth of 150 mesh size.
The formulations of the present invention are not a mere admixture resulting in mere aggregation of the properties of individual ingredients but in a synergistic mixture resulting in enhanced curative properties. Also the clinical trial has been conducted on this newly developed herbal composition and it is surprisingly found that efficacy is improved by using this formulation instead of using individual ingredients of the formulation. Also the clinical trials have been conducted on the patients suffering from the Psoriasis. All have applied the formulation of the present invention on their skin externally once or twice a day depending on the extent of Psoriasis and it has been found that patients get cured in a shorter span of time with least or no side effects. Extent of side effect is varying from person to person. No severe side effect is found.
Example:
The example tells about only the best method of performing the invention. Hence it is considered only for illustration purpose and not for limiting the scope of invention.
Firstly the herbs are selected and cultivated in the red soil using bio-fertilizer manure or all natural waste. These are harvested in Non-sunlight after the maturity period and cut after 10 or 12 days in a non-sunlight or shed with hygienic condition preferably on stone. Subsequently dried in sunlight for 1 to 2 days. Then extracts of above herbs in following percentage by weight are selected:
1. 13 % by weight fruit extract of Ritha (Sapindus trifoliatus)
2. 18% by weight leaf extract of Medasinghi (Gymnema sylvastre)
3. 12% by weight fruit & seed extract of AmIa (Phyllanthus emblica)
4. 10% by weight leaf extract of Kalmegh (Andrographis paniculata)
5. 3% by weight root extract of Veeranmool (Andropogan muricatus)
6. 5% by weight leaf extract of Kalyani (Cassia obovata)
7. 10% by weight stem and leaf extract of Wonga (Achyrantus aspera)
8. 12% by weight stem and leaf extract of Bhangra (Eclipta prostrata)
9. 12% by weight root extract of Haldi (Curcuma longa)
10. 5 % by weight root extract of Aswagandha (Withania somnif era)
Then herb extract are grinded separately in a grinder with 1500 rpm to make powder form and pulverized/blended in the specific proportion as given above in the pulverizer/blender for thorough mixing with speed of 500 rpm for 45 minutes. Then resultant mixture sieved through the nylon cloth of 150 mesh size to obtain the required particle size of the active ingredients which. The formulation of the present invention is available in powdered form.
However, it should be understood that the invention is not limited in this regard, and the relative amounts of these ingredients can be varied to achieve similar results.
Industrial Applicability
The invention provides herbal composition for curing Psoriasis which is very well used in the medicinal field and drug industries.
Claims
1. A process for manufacturing an herbal composition comprises the steps of: a. selecting the extracts of the following Herbs in the given percentage by weight:
1. 13 % by weight fruit extract of Ritha (Sapindus trifoliatus)
2. 18% by weight leaf extract of Medasinghi (Gymnema sylvastre)
3. 12% by weight fruit & seed extract of AmIa (Phyllanthus emblica)
4. 10% by weight leaf extract of Kalmegh (Andrographis paniculata)
5. 3% by weight root extract of Veeranmool (Andropogan muricatus)
6. 5% by weight leaf extract of Kalyani (Cassia obovata)
7. 10% by weight stem and leaf extract of Wonga (Achyrantus aspera)
8. 12% by weight stem and leaf extract of Bhangra (Eclipta prostata)
9. 12% by weight root extract of Haldi (Curcuma longa)
10. 5% by weight root extract of Aswagandha (Withania somnifera)
wherein aforesaid mentioned herbal extracts are cultivated in red soil and harvested in non-sunlight after the maturity period and cut in non-sunlight in a hygienic condition probably on clean stone for hygienic purpose and dryed in sunlight before grinding for one to two days;
b. grinding the above Herbs separately in a grinder at a speed of 1500 rpm; c. pulverizing/blending the ingredients in their specific proportion as given above in a pulverizer/ blender run at a speed of 500 rpm for 30 to 60 minutes; d. sieving the mixed powder through a sieve made of nylon cloth of 150 mesh size.
2. A herbal composition comprises:
1. 13 % by weight fruit extract of Ritha (Sapindus trifoliatus)
.2. 18% by weight leaf extract of Medasinghi (Gymnema sylvastre)
3. 12% by weight fruit & seed extract of AmIa (Phyllanthus emblica)
4. 10% by weight leaf extract of Kalmegh (Andrographis paniculata)
5. 3% by weight root extract of Veeranmool (Andropogan muricatus)
6. 5 % by weight leaf extract of Kalyani (Cassia obovata)
7. 10% by weight stem and leaf extract of Wonga (Achyrantus aspera)
8. 12% by weight stem and leaf extract of Bhangra (Eclipta prostrata)
9. 12% by weight root extract of Haldi (Curcuma longa)
10. 5% by weight root extract of Aswagandha (Withania somnifera)
3. An herbal composition as claimed in claim 2 is in powdered form.
4. An herbal composition as claimed in claim 2 used for curing Psoriasis.
5. A process for manufacturing a herbal composition as herein described with reference to example.
6. An herbal composition as herein described with reference to example.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN923MU2006 | 2006-06-13 | ||
| IN923/MUM/2006 | 2006-06-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008015698A2 true WO2008015698A2 (en) | 2008-02-07 |
| WO2008015698A3 WO2008015698A3 (en) | 2008-10-09 |
Family
ID=38997577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2007/000214 WO2008015698A2 (en) | 2006-06-13 | 2007-05-28 | A process for manufacturing an herbal composition for curing psoriasis and herbal composition made thereof |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008015698A2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110206789A1 (en) * | 2008-04-10 | 2011-08-25 | Prime Interaction Holdings Limited | HERBAL EXTRACT PRODUCTS AND METHODS (as amended) |
| FR3015284A1 (en) * | 2013-12-24 | 2015-06-26 | Clarins Lab | COSMETIC USE OF A GYMNEMA SYLVESTRE EXTRACT |
| WO2015148523A1 (en) * | 2014-03-24 | 2015-10-01 | De Souza Louise | Soluble composition for treatment of hair and skin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0923937B1 (en) * | 1997-12-08 | 2004-03-10 | Council of Scientific and Industrial Research | A herbal formulation useful as a therapeutic and cosmetic application for the treatment of general skin disorders |
| US6368639B1 (en) * | 2000-03-24 | 2002-04-09 | Council Of Scientific And Industrial Research | Herbal skin care formulation and a process for the preparation thereof |
| WO2002096440A1 (en) * | 2001-05-31 | 2002-12-05 | Virendrakumar Jain | Cow urine therapy and herbal medicinal composition with cow urine and method of manufacturing the same |
| JP2005239715A (en) * | 2004-02-04 | 2005-09-08 | Omboon Luanratana | Medicinal cosmetic composition to alleviate photoaging |
-
2007
- 2007-05-28 WO PCT/IN2007/000214 patent/WO2008015698A2/en active Application Filing
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110206789A1 (en) * | 2008-04-10 | 2011-08-25 | Prime Interaction Holdings Limited | HERBAL EXTRACT PRODUCTS AND METHODS (as amended) |
| US8673375B2 (en) * | 2008-04-10 | 2014-03-18 | Prime Interaction Holdings Limited | Herbal extract products and methods |
| FR3015284A1 (en) * | 2013-12-24 | 2015-06-26 | Clarins Lab | COSMETIC USE OF A GYMNEMA SYLVESTRE EXTRACT |
| WO2015097601A1 (en) * | 2013-12-24 | 2015-07-02 | Laboratoires Clarins | Cosmetic use of an extract of gymnema sylvestre |
| RU2682963C2 (en) * | 2013-12-24 | 2019-03-25 | Лаборатуар Кларанс | Cosmetic use of extract of gymnema sylvestre |
| WO2015148523A1 (en) * | 2014-03-24 | 2015-10-01 | De Souza Louise | Soluble composition for treatment of hair and skin |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008015698A3 (en) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107158297A (en) | It is a kind of to treat traditional Chinese medicinal ointment of Orthopedic Pain and preparation method thereof | |
| WO2008015698A2 (en) | A process for manufacturing an herbal composition for curing psoriasis and herbal composition made thereof | |
| KR101764131B1 (en) | External preparation for skin comprising aloe extracts and capsaicin | |
| CN114081938B (en) | Bee therapy patch and preparation method thereof | |
| WO2008015697A2 (en) | A process for manufacturing an herbal composition for relieving pain from joints and bones | |
| CN108272947A (en) | A kind of blood-activating analgesic plaster and preparation method thereof | |
| CN102302571B (en) | Chinese medicinal composition for treating bony spur diseases and preparation method and application thereof | |
| CN107213347A (en) | It is a kind of to treat orthopaedics bone-set plaster of fracture and preparation method thereof | |
| CN111773341A (en) | A compound Chinese herbal medicine external preparation for treating scabies of piglets | |
| CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
| JP2000273046A (en) | Treating agent for skin disease | |
| CN105079206A (en) | A traditional Chinese medicine composition with analgesic effect and preparation method thereof | |
| CN1054522C (en) | Sichuan aconite root analgesic soft extract | |
| CN1082418A (en) | Treatment fracture, osteomiosis one-day cure Chinese herbal medicine product | |
| CN1181861C (en) | Spray agent for treating tendon and bone injury | |
| CN116763834B (en) | Traditional Chinese medicine composition and preparation for treating arthralgia as well as preparation method and application of traditional Chinese medicine composition and preparation | |
| CN1055845C (en) | Dieda Huoxuesan powder for curing fracture and injury | |
| CN104998023B (en) | It is a kind of for treating the pharmaceutical composition and ointment of acne, furuncle | |
| CN103285318B (en) | External pharmaceutical composition for surgery and orthopedics | |
| CN114762719A (en) | Traditional Chinese medicine composition for relaxing tendons and activating collaterals and preparation method thereof | |
| CN120241914A (en) | A Chinese patent medicine external application ointment for treating neck, shoulder, waist and leg pain and its preparation method | |
| CN111544560A (en) | Traditional Chinese medicine composition for treating eczema | |
| CN101156902A (en) | A externally used traditional Chinese medicine preparation for treating injuries from falls as well as its preparation method | |
| CN120053546A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and shoulder, neck, waist and leg pain and preparation method | |
| CN112168684A (en) | Moxa cone for treating cyst, nodule, hyperplasia and tumor and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A DATED 29.05.09 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07827506 Country of ref document: EP Kind code of ref document: A2 |